Optimizing Quadruple Guideline-Directed Therapy for Heart Failure with Reduced Ejection Fraction

Summary

This article discusses the importance of optimizing guideline-directed medical therapy (GDMT) for heart failure patients, specifically focusing on quadruple therapy approaches. Dr. Carolyn Lam, a senior consultant cardiologist, outlines the evidence-based framework for treating heart failure with reduced ejection fraction (HFrEF), emphasizing the need for timely initiation and up-titration of four foundational drug classes: beta-blockers, ACE inhibitors/ARB/ARNI, mineralocorticoid receptor antagonists (MRAs), and SGLT2 inhibitors. The piece highlights clinical inertia as a major barrier and provides strategies for implementing comprehensive care pathways to improve patient outcomes.

Source

Twitter / XOptimizing Quadruple Guideline-Directed Therapy for Heart Failure with Reduced Ejection Fractionmdsc.pe